Efficacy of zolpidem for dystonia: A study among different subtypes

Frontiers in Neurology

Volumn APR, Issue , 2012, Pages

  Miyazaki, Yoshimichi ^a,b   Sako, Wataru ^a,c   Asanuma, Kotaro ^a   Izumi, Yuishin ^a   Miki, Tetsuro ^a   Kaji, Ryuji ^a,c  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Generalized dystonia; Hand dystonia; Meige syndrome; Zolpidem

Indexed keywords

EID: 84865851195     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00058     Document Type: Article

References (22)

1. Albanese, A., Barnes, M. P., Bhatia, K. P., Fernandez-Alvarez, E., Filippini, G., Gasser, T., Krauss, J. K., Newton, A., Rektor, I., Savoiardo, M., and Valls-Solè, J. (2006). A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES task force. Eur. J. Neurol. 13, 433-444.
2. An, J. Y., Kim, J. S., Kim, Y. I., and Lee, K. S. (2008). Successful treatment of the Meige syndrome with oral zolpidem monotherapy. Mov. Dis-ord. 23, 1619-1621.
3. Burke, R. E., Fahn, S., Marsden, C. D., Bressman, S. B., Moskowitz, C., and Friedman, J. (1985). Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35, 73-77.
4. Chen, L., Savio, C. C., and Yung, W. H. (2004). Electrophysiological and behavioral effects of zolpidem in rat globus pallidus. Exp. Neurol. 186, 212-220.
5. Chen, L., Xie, J. X., Fung, K. S., and Yung, W. H. (2007). Zolpidem modulates GABA(A) receptor function in subthalamic nucleus. Neurosci. Res. 58, 77-85.
6. Daniele, A., Albanese, A., Gainotti, G., Gregori, B., and Bartolomeo, P. (1997). Zolpidem in Parkinson's disease. Lancet 349, 1222-1223.
7. Duncan, G. E., Breese, G. R., Criswell, H. E., McCown, T. J., Herbert, J. S., Devaud, L. L., and Morrow, A. L. (1995). Distribution of [3H] zolpidem binding sites in relation to messenger RNA encoding the a1, ß2 and γ2 subunits of GABAA receptors in rat brain. Neuroscience 64, 1113-1128.
8. Evidente, V. G. (2002). Zolpidem improves dystonia in Lubag or X-linked dystonia-parkinsonism syndrome. Neurology 26, 662-663.
9. Fahn, S., Bressman, S. B., and Marsden, C. D. (1998). Classification of dystonia. Adv. Neurol. 78, 1-10.
10. Garretto, N. S., Bueri, J. A., Rey, R. D., Arakaki, T., Nano, G. V., and Man-cuso, M. (2004). Improvement of blepharospasm with zolpidem. Mov. Disord. 19, 967-968.
11. Holm, K. J., and Goa, K. L. (2000). Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs 59, 865-889.
12. Jabbari, B., Scherokaman, B., Gunder-son, C. H., Rosenberg, M. L., and Miller, J. (1989). Treatment of movement disorders with trihexy-phenidyle. Mov. Disord. 4, 202-212.
13. Karp, B. I., Cole, R. A., Cohen, L. G., Grill, S., Lou, J. S., and Hallett, M. (1994). Long-term botulinum toxin treatment of focal hand dystonia. Neurology 44, 70-76.
14. Lee, J. Y., Deogankar, M., and Rezai, A. (2007). Deep brain stimulation of globus pallidus internus for dystonia. Parkinsonism Relat. Disord. 13, 261-265.
15. Licata, S. C., Jensen, J. E., Pene-tar, D. M., Prescot, A. P., Lukas, S. E., and Renshaw, P. F. (2009). A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T. Psychopharmacology (Berl.) 203, 819-829.
16. McKernan, R. M., and Whiting, P. J. (1996). Which GABAA-receptor subtypes really occur in the brain?. Tends Neurosci. 19, 139-143.
17. Park, I. S., Kim, J. S., An, J. Y., Kim, Y. L., and Lee, K. S. (2009). Excellent response to oral zolpidem in a sporadic case of the myoclonus dystonia syndrome. Mov. Disord. 24, 2172-2173.
18. Sanna, E., Busonero, F., Talani, G., Carta, M., Massa, F., Peis, M., Maciocco, M., and Biggio, G. (2002). Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes. Eur. J. Pharmacol. 451, 103-110.
19. Sheehy, M. P., and Marsden, C. D. (1982). Writer's cramp: a focal dystonia. Brain 105, 461-480.
20. Starr, P. A., Turner, R. S., Rau, G., Lindsey, N., Heath, S., Volz, M., Ostrem, J. L., and Marks, W. J. Jr. (2006). Microelectrode-guided implantation of deep stimulators into the globus pallidus internus for dystonia: techniques, electrode locations, and out comes. J. Neurosurg. 104, 488-501.
21. Weiss, E. M., Hershey, T., Karimi, M., Racette, B., Tabbal, S. D., Mink, J. W., Paniello, R. C., and Perlmutter, J. S. (2006). Relative risk of spread of symptoms among the focal onset primary dystonias. Mov. Disord. 21, 1175-1181.
22. Young, J., Kim, J. S., Kim, Y. I., and Lee, K. S. (2008). Successful treatment of the Meige syndrome with oral zolpidem monotherapy. Mov. Disord. 23, 1619-1620.